John Thoms

1.5k total citations
33 papers, 761 citations indexed

About

John Thoms is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, John Thoms has authored 33 papers receiving a total of 761 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 17 papers in Oncology and 7 papers in Surgery. Recurrent topics in John Thoms's work include Cancer-related cognitive impairment studies (9 papers), Cancer survivorship and care (9 papers) and Prostate Cancer Treatment and Research (8 papers). John Thoms is often cited by papers focused on Cancer-related cognitive impairment studies (9 papers), Cancer survivorship and care (9 papers) and Prostate Cancer Treatment and Research (8 papers). John Thoms collaborates with scholars based in Canada, United States and Netherlands. John Thoms's co-authors include Robert G. Bristow, Michael Milosevic, Theodorus van der Kwast, Jenna Sykes, Siham Sabri, Jean Deschênes, Bassam Abdulkarim, Neil Fleshner, Padraig Warde and Alice Meng and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

John Thoms

29 papers receiving 753 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Thoms Canada	15	359	216	215	207	125	33	761
Kristian Novakovic United States	14	397 1.1×	308 1.4×	82 0.4×	153 0.7×	92 0.7×	21	711
António Fernández Spain	11	103 0.3×	233 1.1×	201 0.9×	262 1.3×	190 1.5×	31	753
Stephan Tschirdewahn Germany	16	269 0.7×	197 0.9×	159 0.7×	234 1.1×	174 1.4×	57	677
Savvas Papadopoulos Greece	14	248 0.7×	389 1.8×	157 0.7×	156 0.8×	55 0.4×	41	659
Tomohiro Fujii Japan	19	310 0.9×	261 1.2×	65 0.3×	216 1.0×	155 1.2×	47	887
Anja Pickhard Germany	17	401 1.1×	385 1.8×	121 0.6×	331 1.6×	174 1.4×	61	1.1k
Brent F.G. Treiger United States	10	276 0.8×	166 0.8×	147 0.7×	329 1.6×	122 1.0×	11	763
David L. Shepherd United States	9	482 1.3×	238 1.1×	111 0.5×	205 1.0×	72 0.6×	16	742
Helen P. Kourea Greece	16	232 0.6×	232 1.1×	106 0.5×	270 1.3×	181 1.4×	29	844
David Hall United States	14	156 0.4×	261 1.2×	161 0.7×	244 1.2×	113 0.9×	30	846

Countries citing papers authored by John Thoms

Since Specialization

Citations

This map shows the geographic impact of John Thoms's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Thoms with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Thoms more than expected).

Fields of papers citing papers by John Thoms

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Thoms. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Thoms. The network helps show where John Thoms may publish in the future.

Co-authorship network of co-authors of John Thoms

This figure shows the co-authorship network connecting the top 25 collaborators of John Thoms. A scholar is included among the top collaborators of John Thoms based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Thoms. John Thoms is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rash, Joshua A., Josée Savard, Melanie Seal, et al.. (2025). Impact and Mechanisms of Cognitive Behavioural Therapy for Insomnia on Fatigue among Cancer Survivors: A Secondary Analysis of a Randomized Controlled Trial. SLEEP. 48(6). 3 indexed citations

Rash, Joshua A., Josée Savard, Melanie Seal, et al.. (2025). Factors associated with significant improvement in cancer-related fatigue after completing cognitive behavioral therapy for insomnia in cancer survivors. Supportive Care in Cancer. 33(5). 432–432. 1 indexed citations

Laing, Kara, Joshua A. Rash, Josée Savard, et al.. (2025). The effect of insomnia treatment on work productivity and related costs among cancer survivors with insomnia and comorbid perceived cognitive impairments: A secondary analysis of a randomized controlled trial. Journal of Cancer Survivorship.

Savard, Josée, Joshua A. Rash, Christopher Quinn‐Nilas, et al.. (2025). Impact of treatment credibility and expectancy on cognitive behavioral therapy for insomnia outcomes among cancer survivors. Journal of Psychosomatic Research. 200. 112447–112447.

Garland, Sheila N., Josée Savard, Joshua A. Rash, et al.. (2024). Randomized Controlled Trial of Virtually Delivered Cognitive Behavioral Therapy for Insomnia to Address Perceived Cancer-Related Cognitive Impairment in Cancer Survivors. Journal of Clinical Oncology. 42(17). 2094–2104. 12 indexed citations

Garland, Sheila N., Joshua A. Rash, Melanie Seal, et al.. (2023). 0827 Effect of virtual cognitive behavioral therapy for insomnia on perceived cognitive functioning among cancer survivors. SLEEP. 46(Supplement_1). A364–A364.

Rash, Joshua A., et al.. (2021). Androgen deprivation therapy and radiation for prostate cancer—cognitive impairment, sleep, symptom burden: a prospective study. BMJ Supportive & Palliative Care. 13(e2). e454–e463. 14 indexed citations

Garland, Sheila N., Josée Savard, Richard J. Wassersug, et al.. (2021). A 2‐year prospective analysis of insomnia as a mediator of the relationship between androgen deprivation therapy and perceived cognitive function in men with prostate cancer. Cancer. 127(24). 4656–4664. 14 indexed citations

Garland, Sheila N., Josée Savard, Melanie Seal, et al.. (2021). Rationale and protocol for a randomized waitlist controlled trial of videoconference delivered cognitive behaviour therapy for insomnia (CBT-I) to improve perceived cognitive impairment (PCI) among cancer survivors. Contemporary Clinical Trials. 103. 106322–106322. 13 indexed citations

10.

Kao, Kenneth R., et al.. (2017). PYGOPUS2 expression in prostatic adenocarcinoma is a potential risk stratification marker for PSA progression following radical prostatectomy. Journal of Clinical Pathology. 71(5). 402–411. 6 indexed citations

11.

Boström, Peter J., John Thoms, Jenna Sykes, et al.. (2016). Hypoxia Marker GLUT-1 (Glucose Transporter 1) is an Independent Prognostic Factor for Survival in Bladder Cancer Patients Treated with Radical Cystectomy. Bladder Cancer. 2(1). 101–109. 30 indexed citations

12.

Zafarana, Gaetano, Adrian Ishkanian, Chad A. Malloff, et al.. (2012). Copy number alterations of c‐MYC and PTEN are prognostic factors for relapse after prostate cancer radiotherapy. Cancer. 118(16). 4053–4062. 92 indexed citations

13.

Thoms, John, Alan Dal Pra, Pieter H. Anborgh, et al.. (2012). Plasma osteopontin as a biomarker of prostate cancer aggression: relationship to risk category and treatment response. British Journal of Cancer. 107(5). 840–846. 49 indexed citations

14.

Locke, Jennifer A., Gaetano Zafarana, Adrian Ishkanian, et al.. (2011). NKX3.1 Haploinsufficiency Is Prognostic for Prostate Cancer Relapse following Surgery or Image-Guided Radiotherapy. Clinical Cancer Research. 18(1). 308–316. 32 indexed citations

15.

Beucken, Twan van den, et al.. (2011). Hypoxia disrupts the Fanconi anemia pathway and sensitizes cells to chemotherapy through regulation of UBE2T. Radiotherapy and Oncology. 101(1). 190–197. 31 indexed citations

16.

Ishkanian, Adrian, Gaetano Zafarana, John Thoms, & Robert G. Bristow. (2010). Array CGH as a potential predictor of radiocurability in intermediate risk prostate cancer. Acta Oncologica. 49(7). 888–894. 20 indexed citations

17.

Thoms, John, Jayant Sastri Goda, Neil Fleshner, et al.. (2010). Neoadjuvant radiotherapy for locally advanced and high-risk prostate cancer. Nature Reviews Clinical Oncology. 8(2). 107–113. 27 indexed citations

18.

Thoms, John & Robert G. Bristow. (2010). DNA Repair Targeting and Radiotherapy: A Focus on the Therapeutic Ratio. Seminars in Radiation Oncology. 20(4). 217–222. 67 indexed citations

19.

Lesniak, David, Yaoxian Xu, Jean Deschênes, et al.. (2009). β1-Integrin Circumvents the Antiproliferative Effects of Trastuzumab in Human Epidermal Growth Factor Receptor-2–Positive Breast Cancer. Cancer Research. 69(22). 8620–8628. 71 indexed citations

20.

Bohuslavizki, K. H., Susanne Klutmann, Uwe Sonnemann, et al.. (1999). F-18-FDG-PET zur Detektion des okkulten Primärtumors bei Patienten mit Lymphknotenmetastasen der Halsregion. Laryngo-Rhino-Otologie. 78(8). 445–449. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact